SUNPHARMA - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth

1.0%

2.2%

7.2%

23.4%

20.1%

63.9%

35.9%

10y

9.5%

all

18.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,865 1.0%

1,457

1,871

Company Overview

Sales

49,209 Cr

Growth: 10.3%

Profit after Tax

10,389 Cr

Growth: 8.5%

Large Cap

4,47,464 Cr

P/E: 43.1x

Industry P/E: 42.8x

Fundamentals

Sales (Cr)	₹ 49,209
Growth	10.3%
EBITDA	26.8%
P/S	9.1x
Dividend	0.9%
P/E	43.1x
Book Value	₹ 277
PEG Ratio	4.2x
ROE	16.4%
P/B	6.7x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

7.37 %

Icici Prudential Value Discovery Fund And Various Fund Accounts

3.68 %

Sbi-Etf Nifty 50 And Various Fund Accounts

1.94 %

Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts

1.37 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts

1.24 %

Promoters

Shanghvi Finance Private Limited

40.3 %

Dilip.S.Shanghvi

9.6 %

Aditya Medisales Limited

1.67 %

Raksha S.Valia

1.2 %

Sudhir V.Valia

0.6 %

Others

Llp

2.89 %

Lakshdeep Investments & Finance (P) Ltd.

1.18 %

Iepf

0.08 %

Increase Decrease No change

Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.

Belongs to (40 Indices) view more

Investors (335)

subson

anil.kum...

rakesh.m...

Followers (135)

bharath....

kiran198...

anil